CA Patent

CA2459454A1 — Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists

Assigned to Bayer Pharmaceuticals Corp · Expires 2003-03-27 · 23y expired

What this patent protects

This invention relates to novel benzofuran and dihydrobenzofuran compounds, pharmaceutical compositions containing such compounds, and methods of treati ng beta-3 adrenoreceptor-mediated conditions with such compositions.

USPTO Abstract

This invention relates to novel benzofuran and dihydrobenzofuran compounds, pharmaceutical compositions containing such compounds, and methods of treati ng beta-3 adrenoreceptor-mediated conditions with such compositions.

Drugs covered by this patent

Patent Metadata

Patent number
CA2459454A1
Jurisdiction
CA
Classification
—
Expires
2003-03-27
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharmaceuticals Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.